CervoMed Correlations

CRVO Stock   7.41  0.44  6.31%   
The current 90-days correlation between CervoMed and Gain Therapeutics is 0.25 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CervoMed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CervoMed moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

CervoMed Correlation With Market

Average diversification

The correlation between CervoMed and DJI is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CervoMed and DJI in the same portfolio, assuming nothing else is changed.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CervoMed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
To learn how to invest in CervoMed Stock, please use our How to Invest in CervoMed guide.

Moving together with CervoMed Stock

  0.81OPTI OptiBiotix Health PlcPairCorr
  0.61688238 OBiO Technology CorpPairCorr
  0.89688089 Cabio Biotech WuhanPairCorr
  0.71300439 Ningbo MedicalSystemPairCorr
  0.78300942 Shenzhen Bioeasy BioPairCorr
  0.81METROPOLIS Metropolis HealthcarePairCorr
  0.61300871 Wuhan Hvsen BiotechnologyPairCorr
  0.73OBI Ondine BiomedicalPairCorr
  0.81688166 BrightGene Bio MedicalPairCorr

Moving against CervoMed Stock

  0.87ZYME Zymeworks Common StockPairCorr
  0.78IMNM Immunome Earnings Call This WeekPairCorr
  0.76ZBIO Zenas BioPharma, CommonPairCorr
  0.63UPB Upstream Bio,PairCorr
  0.6DYAI Dyadic InternationalPairCorr
  0.4603122 Cowealth Medical ChinaPairCorr
  0.39VYNE Vyne TherapeuticsPairCorr
  0.78ANAB AnaptysBioPairCorr
  0.71600201 Jinyu Bio TechnologyPairCorr
  0.6REGN Regeneron PharmaceuticalsPairCorr
  0.56QNRX Quoin PharmaceuticalsPairCorr
  0.48CIZ Cizzle BiotechnologyPairCorr
  0.47ABCL Abcellera BiologicsPairCorr
  0.44MURA Mural Oncology plcPairCorr
  0.38NTLA Intellia TherapeuticsPairCorr
  0.34PYPD PolyPidPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

LITSXBIT
OSTXADAG
ACETNTRB
NRXPNTRB
NRXPACET
OSTXXBIT
  

High negative correlations

VTVTLITS
VTVTXBIT
LITSNRXP
LITSACET
VTVTADAG
VTVTOSTX

Risk-Adjusted Indicators

There is a big difference between CervoMed Stock performing well and CervoMed Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze CervoMed's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
GANX  4.65  0.79  0.22  0.35  4.05 
 11.36 
 25.41 
ADAG  4.25  0.03 (0.01) 0.20  5.47 
 10.14 
 37.74 
XBIT  2.64 (0.25) 0.00 (0.02) 0.00 
 5.82 
 16.38 
OSTX  3.22  0.02  0.02  0.13  4.08 
 6.39 
 26.06 
NTRB  3.24 (0.37) 0.00 (0.07) 0.00 
 8.42 
 26.20 
ACET  4.16  0.12  0.03  0.22  5.06 
 9.41 
 35.48 
NRXP  3.75  0.05  0.03  0.15  4.10 
 9.55 
 23.02 
FBIO  4.35  0.73  0.08 (0.93) 6.27 
 9.38 
 61.44 
LITS  4.95 (1.31) 0.00 (0.57) 0.00 
 7.73 
 36.65 
VTVT  2.70  1.12  0.37  1.56  2.01 
 7.57 
 20.53 

CervoMed Corporate Management

Dr CobuzziChief OfficerProfile
Mark RoschGovernment RegulatoryProfile
Claudia MDSenior ScienceProfile
John TannerChief OfficerProfile
Matthew WintonChief OfficerProfile
Marinus VerwijsExecutive OperationsProfile